Kostourou et al. reported that overexpression of DDAH1 is associated with increased neovascularization of gliomas in vivo, and Vanella et al. suggested that DDAH2 might contribute to tumor angiogenesis in prostate cancer through an increase of NO production [26, 27]. Here, DDAH2 is linked to prostate cancer.